Enhanced GABAergic inputs contribute to functional alterations of cholinergic interneurons in the r6/2 mouse model of huntington’s disease

eNeuro

Volumn 2, Issue 1, 2015, Pages

  Holley, Sandra M ^a   Joshi, Prasad R ^a   Parievsky, Anna ^a   Huynh, My N ^a   Cepeda, Carlos ^a   Levine, Michael S ^a   Galvan, Laurie ^a   Chen, Jane Y ^a   Fisher, Yvette E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cholinergic interneurons; GABA; Huntington s disease; Optogenetics; R6 2 mouse model; Striatum

Indexed keywords

EID: 85046766689     PISSN: None     EISSN: 23732822     Source Type: Journal    
DOI: 10.1523/ENEURO.0008-14.2015     Document Type: Article

References (46)

1. Ariano MA, Cepeda C, Calvert CR, Flores-Hernández J, Hernández-Echeagaray E, Klapstein GJ, Chandler SH, Aronin N, DiFiglia M, Levine MS (2005) Striatal potassium channel dysfunction in Huntington’s disease transgenic mice. J Neurophysiol 93:2565-2574. CrossRef Medline
2. Bates G, Harper PS, Jones L (2002) Huntington’s disease, 3rd Edition. Oxford: Oxford UP.
3. Bennett BD, Wilson CJ (1998) Synaptic regulation of action potential timing in neostriatal cholinergic interneurons. J Neurosci 18:8539-8549. Medline
4. Ariano MA, Cepeda C, Calvert CR, Flores-Hernández J, Hernández-Echeagaray E, Klapstein GJ, Chandler SH, Aronin N, DiFiglia M, Levine MS (2005) Striatal potassium channel dysfunction in Huntington’s disease transgenic mice. J Neurophysiol 93:2565-2574. CrossRef Medline
5. Bennett BD, Callaway JC, Wilson CJ (2000) Intrinsic membrane properties underlying spontaneous tonic firing in neostriatal cholinergic interneurons. J Neurosci 20:8493-8503. Medline
6. Bird ED (1980) Chemical pathology of Huntington’s disease. Annu Rev Pharmacol Toxicol 20:533-551. CrossRef Medline
7. Cardin JA, Carlén M, Meletis K, Knoblich U, Zhang F, Deisseroth K, Tsai LH, Moore CI (2009) Driving fast-spiking cells induces gamma rhythm and controls sensory responses. Nature 459:663-667. CrossRef Medline
8. Cepeda C, Itri JN, Flores-Hernandez J, Hurst RS, Calvert CR, Levine MS (2001) Differential sensitivity of medium- and large-sized striatal neurons to NMDA but not kainate receptor activation in the rat. Eur J Neurosci 14:1577-1589. CrossRef
9. Cepeda C, Hurst RS, Calvert CR, Hernandez-Echeagaray E, Nguyen OK, Jocoy E, Christian LJ, Ariano MA, Levine MS (2003) Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington’s disease. J Neurosci 23:961-969. Medline
10. Cepeda C, Starling AJ, Wu N, Nguyen OK, Uzgil B, Soda T, André VM, Ariano MA, Levine MS (2004) Increased GABAergic function in mouse models of Huntington’s disease: reversal by BDNF. J Neurosci Res 78:855-867. CrossRef Medline
11. Cepeda C, Wu N, André VM, Cummings DM, Levine MS (2007) The corticostriatal pathway in Huntington’s disease. Prog Neurobiol 81:253-271. CrossRef Medline
12. Cepeda C, Galvan L, Holley SM, Rao SP, André VM, Botelho EP, Chen JY, Watson JB, Deisseroth K, Levine MS (2013) Multiple sources of striatal inhibition are differentially affected in Huntington’s disease mouse models. J Neurosci 33:7393-7406. CrossRef Medline
13. Cepeda C, Chen JY, Wu JY, Fisher RS, Vinters HV, Mathern GW, Levine MS (2014) Pacemaker GABA synaptic activity may contribute to network synchronization in pediatric cortical dysplasia. Neurobiol Dis 62:208-217. CrossRef Medline
14. Chuhma N, Tanaka KF, Hen R, Rayport S (2011) Functional connectome of the striatal medium spiny neuron. J Neurosci 31:1183-1192. CrossRef Medline
15. Ariano MA, Cepeda C, Calvert CR, Flores-Hernández J, Hernández-Echeagaray E, Klapstein GJ, Chandler SH, Aronin N, DiFiglia M, Levine MS (2005) Striatal potassium channel dysfunction in Huntington’s disease transgenic mice. J Neurophysiol 93:2565-2574. CrossRef Medline
16. Ding JB, Guzman JN, Peterson JD, Goldberg JA, Surmeier DJ (2010) Thalamic gating of corticostriatal signaling by cholinergic interneurons. Neuron 67:294-307. CrossRef Medline
17. Farrar AM, Callahan JW, Abercrombie ED (2011) Reduced striatal acetylcholine efflux in the R6/2 mouse model of Huntington’s disease: an examination of the role of altered inhibitory and excitatory mechanisms. Exp Neurol 232:119-125. CrossRef Medline
18. Ferrante RJ, Beal MF, Kowall NW, Richardson EP, Jr., Martin JB (1987) Sparing of acetylcholinesterase-containing striatal neurons in Huntington’s disease. Brain Res 411:162-166. Medline
19. Ferrante RJ, Kowall NW, Beal MF, Richardson EP Jr, Bird ED, Martin JB (1985) Selective sparing of a class of striatal neurons in Huntington’s disease. Science 230:561-563. Medline
20. Fusco FR, Chen Q, Lamoreaux WJ, Figueredo-Cardenas G, Jiao Y, Coffman JA, Surmeier DJ, Honig MG, Carlock LR, Reiner A (1999) Cellular localization of huntingtin in striatal and cortical neurons in rats: lack of correlation with neuronal vulnerability in Huntington’s disease. J Neurosci 19:1189-1202. Medline
21. Gonzales KK, Pare JF, Wichmann T, Smith Y (2013) GABAergic inputs from direct and indirect striatal projection neurons onto cholinergic interneurons in the primate putamen. J Comp Neurol 521:2502-2522. CrossRef Medline
22. Graybiel AM (1990) Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci 13:244-254. Medline
23. Graybiel AM (1995) Building action repertoires: memory and learning functions of the basal ganglia. Curr Opin Neurobiol 5:733-741. Medline
24. Gundersen HJ, Jensen EB (1987) The efficiency of systematic sampling in stereology and its prediction. J Microsc 147:229-263. Medline
25. Klapstein GJ, Fisher RS, Zanjani H, Cepeda C, Jokel ES, Chesselet MF, Levine MS (2001) Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington’s disease transgenic mice. J Neurophysiol 86:2667-2677. Medline
26. Kosinski CM, Cha JH, Young AB, Mangiarini L, Bates G, Schiefer J, Schwarz M (1999) Intranuclear inclusions in subtypes of striatal neurons in Huntington’s disease transgenic mice. Neuroreport 10:3891-3896. Medline
27. Lapper SR, Bolam JP (1992) Input from the frontal cortex and the parafascicular nucleus to cholinergic interneurons in the dorsal striatum of the rat. Neuroscience 51:533-545. Medline
28. Ariano MA, Cepeda C, Calvert CR, Flores-Hernández J, Hernández-Echeagaray E, Klapstein GJ, Chandler SH, Aronin N, DiFiglia M, Levine MS (2005) Striatal potassium channel dysfunction in Huntington’s disease transgenic mice. J Neurophysiol 93:2565-2574. CrossRef Medline
29. Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hether-ington C, Lawton M, Trottier Y, Lehrach H, Davies SW, Bates GP (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87:493-506. CrossRef
30. Martone ME, Armstrong DM, Young SJ, Groves PM (1992) Ultrastructural examination of enkephalin and substance P input to cholinergic neurons within the rat neostriatum. Brain Res 594:253-262. Medline
31. Meade CA, Deng YP, Fusco FR, Del Mar N, Hersch S, Goldowitz D, Reiner A (2002) Cellular localization and development of neuronal intranuclear inclusions in striatal and cortical neurons in R6/2 transgenic mice. J Comp Neurol 449:241-269. CrossRef Medline
32. Pakhotin P, Bracci E (2007) Cholinergic interneurons control the excitatory input to the striatum. J Neurosci 27:391-400. CrossRef Medline
33. Picconi B, Passino E, Sgobio C, Bonsi P, Barone I, Ghiglieri V, Pisani A, Bernardi G, Ammassari-Teule M, Calabresi P (2006) Plastic and behavioral abnormalities in experimental Huntington’s disease: a crucial role for cholinergic interneurons. Neurobiol Dis 22:143-152. CrossRef Medline
34. Pisani A, Bernardi G, Ding J, Surmeier DJ (2007) Re-emergence of striatal cholinergic interneurons in movement disorders. Trends Neurosci 30:545-553. CrossRef Medline
35. Reiner A, Albin RL, Anderson KD, D’Amato CJ, Penney JB, Young AB (1988) Differential loss of striatal projection neurons in Huntington disease. Proc Natl Acad Sci USA85:5733-5737. Medline
36. Reiner A, Shelby E, Wang H, Demarch Z, Deng Y, Guley NH, Hogg V, Roxburgh R, Tippett LJ, Waldvogel HJ, Faull RL (2013) Striatal parvalbuminergic neurons are lost in Huntington’s disease: implications for dystonia. Mov Disord 28:1691-1699. CrossRef Medline
37. Sadikot AF, Parent A, François C (1992) Efferent connections of the centromedian and parafascicular thalamic nuclei in the squirrel monkey: a PHA-L study of subcortical projections. J Comp Neurol 315:137-159. CrossRef Medline
38. Smith R, Chung H, Rundquist S, Maat-Schieman ML, Colgan L, Englund E, Liu YJ, Roos RA, Faull RL, Brundin P, Li JY (2006) Cholinergic neuronal defect without cell loss in Huntington’s disease. Hum Mol Genet 15:3119-3131. CrossRef Medline
39. Smith Y, Bevan MD, Shink E, Bolam JP (1998) Microcircuitry of the direct and indirect pathways of the basal ganglia. Neuroscience 86:353-387. CrossRef Medline
40. Sohal VS, Zhang F, Yizhar O, Deisseroth K (2009) Parvalbumin neurons and gamma rhythms enhance cortical circuit performance. Nature 459:698-702. CrossRef Medline
41. Sullivan MA, Chen H, Morikawa H (2008) Recurrent inhibitory network among striatal cholinergic interneurons. J Neurosci 28:8682-8690. CrossRef Medline
42. Szydlowski SN, Pollak Dorocic I, Planert H, Carlén M, Meletis K, Silberberg G (2013) Target selectivity of feedforward inhibition by striatal fast-spiking interneurons. J Neurosci 33:1678-1683. CrossRef Medline
43. Ariano MA, Cepeda C, Calvert CR, Flores-Hernández J, Hernández-Echeagaray E, Klapstein GJ, Chandler SH, Aronin N, DiFiglia M, Levine MS (2005) Striatal potassium channel dysfunction in Huntington’s disease transgenic mice. J Neurophysiol 93:2565-2574. CrossRef Medline
44. Vetter JM, Jehle T, Heinemeyer J, Franz P, Behrens PF, Jackisch R, Landwehrmeyer GB, Feuerstein TJ (2003) Mice transgenic for exon 1 of Huntington’s disease: properties of cholinergic and dopaminergic pre-synaptic function in the striatum. J Neurochem 85:1054-1063. Medline
45. Vonsattel JP, DiFiglia M (1998) Huntington disease. J Neuropathol Exp Neurol 57:369-384. Medline
46. Won L, Ding Y, Singh P, Kang UJ (2014) Striatal cholinergic cell ablation attenuates L-DOPA induced dyskinesia in Parkinsonian mice. J Neurosci 34:3090-3094. CrossRef Medline